Erratum: Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
Crossref DOI link: https://doi.org/10.1038/bcj.2016.12
Published Online: 2016-03-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Phillips, D C
Xiao, Y
Lam, L T
Litvinovich, E
Roberts-Rapp, L
Souers, A J
Leverson, J D
Text and Data Mining valid from 2016-03-11
Version of Record valid from 2016-03-11
Article History
First Online: 11 March 2016
Free to read: This content has been made available to all.